The University of Hong Kong (HKU) and venture capital firm Gobi Partners have officially launched the Gobi–HKU Fund I, a new investment vehicle designed to accelerate the growth of university spin-off companies. This joint initiative, operating under HKU’s Entrepreneurship Engine Fund, aims to transform cutting-edge academic research into globally competitive commercial ventures. The fund will provide critical capital and strategic support to high-potential startups, reinforcing Hong Kong's status as a burgeoning innovation hub.
A Strategic Partnership for Innovation
The new fund was unveiled at a ceremony attended by key figures from academia, investment, and government, highlighting its collaborative nature. Hosted by HKU leadership, the event featured representatives from Gobi Partners and the Hong Kong Investment Corporation Limited (HKIC). This partnership operates as a fund-of-funds, strategically channeling resources to nurture the most promising startups emerging from the university's research ecosystem.
Professor Stephanie Ma, Interim Vice-President for Research at HKU, emphasized the university's commitment to translating world-class research into tangible innovations. She stated that the collaboration with Gobi Partners strengthens this mission by turning breakthrough discoveries into real-world solutions. This initiative marks a new milestone for HKU, accelerating the development of its most promising spin-off ventures with dedicated investment and support.
Fostering a Vibrant Tech Ecosystem
Chibo Tang, Managing Partner of Gobi Partners, noted that some of the world's most disruptive technologies originate within Hong Kong's universities. He expressed excitement about partnering with HKU to bridge the critical gap between academic research and successful commercialization. The collaboration aims to bring breakthroughs in fields like artificial intelligence, robotics, and biotechnology to the global market.
Clara Chan, CEO of the Hong Kong Investment Corporation Limited, remarked on the fund's role in fostering synergy across key sectors. She highlighted the HKIC's determination to connect investment, industry, academia, and government to build a robust innovation ecosystem. This cross-sectoral approach is designed to inject sustainable, patient capital into foundational research, driving Hong Kong’s high-quality economic development.
Inaugural Investments in Deep Tech
The fund announced its first two investments at the launch event, showcasing its focus on deep technology and immediate deployment of capital. Representatives from Manifold Tech and AilsynBio, the inaugural portfolio companies, were present to share their innovative technologies and future plans. These initial investments signal the fund's commitment to supporting ventures with the potential for significant industry impact.
Manifold Tech specializes in real-time 3D reconstruction algorithms and advanced robotics, leveraging artificial intelligence for rapid scanning and modeling. The company develops products and applications that serve multiple industries by transforming physical spaces into detailed digital assets. Its technology represents the kind of practical, high-impact innovation the Gobi–HKU Fund I seeks to champion.
The second recipient, AilsynBio, operates a proprietary AI platform for peptide-based drug discovery, aiming to shorten development cycles significantly. The platform integrates multi-omics human scientific data to identify novel disease targets and design innovative therapeutic molecules. This investment underscores the fund's focus on supporting breakthroughs in the critical and rapidly evolving biotechnology sector.
The launch of the Gobi–HKU Fund I represents a pivotal moment for Hong Kong's technology landscape, creating a dedicated pathway from laboratory to market. This strategic alliance between a leading academic institution and a seasoned venture capital firm provides more than just funding. It establishes a comprehensive support system poised to cultivate a new generation of globally impactful companies rooted in pioneering research.